GDP ±R PROTOKOLÜ

Kaynaklar:

1- Crump, M., J. Kuruvilla, S. Couban, et al. 2014. "Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12." J Clin Oncol 32(31):3490-3496.

2- Moccia, A., F. Hitz, P. Hoskins et al. 2017. "Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma." Leuk Lymphoma. 2017 Feb;58(2):324-332.